UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000000609
Receipt number R000000736
Scientific Title Randomized Control Study of Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer Patients
Date of disclosure of the study information 2007/09/01
Last modified on 2012/09/14 16:05:20

No. Disposal Last modified on Item of update
1 Insert 2007/02/13 17:37:13
2 Update 2007/02/16 10:22:40 Public title
Acronym
3 Update 2007/08/14 15:59:04 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
4 Update 2008/02/26 18:46:32 Recruitment status
Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
5 Update 2008/07/15 17:16:03 Division name
Division name
6 Update 2008/08/12 10:58:10 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Institute
Institute
Organization
Organization
Category of Funding Organization
7 Update 2008/08/15 10:32:05 Homepage URL
Institute
Institute
Organization
Organization
8 Update 2010/08/25 12:27:05 Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
Address1
Tel1
9 Update 2010/08/25 12:55:27 Recruitment status
Anticipated trial start date
10 Update 2010/09/03 16:44:10 Anticipated trial start date
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2011/12/01 18:43:22 Public title
Public title
Acronym
Acronym
12 Update 2011/12/01 18:49:21 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
13 Update 2011/12/01 18:50:53 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Target sample size
14 Update 2011/12/01 18:59:54 Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
15 Update 2011/12/01 19:01:16 Recruitment status
16 Update 2011/12/06 11:06:57 Public title
Acronym
17 Update 2011/12/06 11:08:37 Interventions/Control_1
Interventions/Control_2
18 Update 2012/09/14 16:05:20 Organization
Name of person sending information
Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Email